COMPOUND WITH CONFIDENCE: PCCA Membership, $895/month.

Notice

Our blog search feature is temporarily unavailable while we work to resolve an issue. We apologize for the inconvenience and appreciate your patience. We’ll restore it as soon as possible.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

2Oral_vs_Topical_Estrogen_What_the_Literature_Is_Showing_about_Health_Risk_Part_Two.png

Oral vs. Topical Estrogen: What the Literature Is Showing about Health Risk (Part Two)

In the first part of this article, Pamela, Nat, and Sara shined a light on new health risk information compounders should consider when providing bioidentical hormone replacement therapy. In this second part of the article, they dive deeper into the BHRT conversation, discussing compounded topical estrogen as an option.

Read More